What does corporate — loss on warrant settlement mean?

This represents the financial loss incurred when the company settles outstanding warrants, typically due to the difference between the fair value of the equity issued and the cash received or the carrying value of the liability. It highlights the cost of capital associated with equity-linked financing instruments. High losses in this area may indicate unfavorable terms in historical financing agreements.

BioSig Technologies, Inc. STEX Corporate — Loss On Warrant Settlement

Similar metrics at other companies

CNKLoss On Settlement Of Warrants

$9.83M—

CNKLoss On Warrants

$0—

BLLNSettlement of common stock warrant liability

$211.25K—

PDYNGain Loss On Warrant Liability

-$1.05M-104%

POWWWarrant Issued For Legal Settlement Related Party

$7.09M—

TEMGain Loss On Warrant Termination

$0-100%

Other financials

Income statement

See full

Revenue$13.0K+8.3%

Gross profit$12.0K-88.9%

Operating income-$35.7M-1,098%

Net income-$46.7M-1,560%

EPS (diluted)-$0.27-92.9%

Balance sheet

See full

Cash & equivalents$6.9M+84.0%

Total debt$15.0K-94.7%

Total equity$159.0M+6,003%

Total assets$173.3M+3,823%

Cash flow

See full

Operating cash flow-$10.2M-813%

CapEx$4.0K-93.1%

Free cash flow-$2.9M+29.4%

Valuation

See full

Market cap$88.66M-56.4%

P/S2,216.6×-5,967×

Profitability

See full

Gross margin80.1%+25.2pp

Operating margin-32,155%-14,261pp

Net margin-25,825%-11,789pp

FCF margin-97,216.7%-106,293pp

Returns & leverage

See full

Return on equity-627.1%—

Debt / equity0×—

Current ratio13.9×+11.5×

Where this comes from

Reported directly by BioSig Technologies, Inc. in its filing.

Tagged under the XBRL concept STEX:LossOnWarrantSettlement.

The official record: BioSig Technologies, Inc.’s 10-K, filed March 31, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioSig Technologies, Inc.'s corporate — loss on warrant settlement.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is BioSig Technologies, Inc.'s corporate — loss on warrant settlement?: BioSig Technologies, Inc. (STEX) reported corporate — loss on warrant settlement of $2.01M in Q4 2025.
What does corporate — loss on warrant settlement mean?: This represents the financial loss incurred when the company settles outstanding warrants, typically due to the difference between the fair value of the equity issued and the cash received or the carrying value of the liability. It highlights the cost of capital associated with equity-linked financing instruments. High losses in this area may indicate unfavorable terms in historical financing agreements.